DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Freedman AN et al.
Benefit / Risk Assessment for Breast Cancer Chemoprevention with Raloxifene or Tamoxifen for Women Age 50 Years or older.
J Clin Oncol 2011;
29: 2327-2333
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.